Allurion Technologies (NYSE:ALUR) Announces Earnings Results

Allurion Technologies (NYSE:ALUR) posted its earnings results on Wednesday. The company reported ($7.00) EPS for the quarter, missing the consensus estimate of ($4.75) by ($2.25), Zacks reports.

Allurion Technologies Trading Down 11.0 %

NYSE ALUR opened at $2.77 on Wednesday. The company has a market cap of $13.27 million, a P/E ratio of -0.23 and a beta of -0.59. The company has a fifty day simple moving average of $4.01 and a 200 day simple moving average of $9.93. Allurion Technologies has a 12-month low of $2.15 and a 12-month high of $98.75.

Analyst Ratings Changes

A number of research analysts recently issued reports on ALUR shares. Chardan Capital reiterated a “neutral” rating and issued a $2.50 price objective on shares of Allurion Technologies in a report on Friday, March 21st. Roth Mkm reiterated a “buy” rating and issued a $16.00 price target on shares of Allurion Technologies in a research report on Friday, March 21st.

About Allurion Technologies

Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.